A significant difference was detected in one of the PD-L2 polymorphisms (rs1009759 A>G), with the G allele higher in the breast cancer patients when compared with the general European population (Table 4, p = 0.038). This evidence concerns the gene PDCD1LG2 and breast carcinoma.